Relationship between aminoglycoside-induced nephrotoxicity and auditory toxicity

Area of Science:

• Pharmacology
• Nephrology
• Ototology

Background:

• Aminoglycosides are widely used antibiotics.
• Potential for ototoxicity and nephrotoxicity necessitates understanding their relationship.

Purpose of the Study:

• To determine if aminoglycoside-induced auditory toxicity and nephrotoxicity are independent events.
• Evaluate patient data from prospective, double-blind aminoglycoside studies.

Main Methods:

• Reviewed data from 391 patients, focusing on 127 cases with >3 days of treatment.
• Included patients with serial creatinine and audiogram data (250-8,000 Hz).
• Investigational teams were blinded to the specific aminoglycoside (gentamicin, tobramycin, amikacin) administered.

Main Results:

• Incidence of auditory toxicity was 18.2% in the nephrotoxic group and 15.2% in the non-nephrotoxic group (P=0.75).
• No significant differences observed in age, total dose, initial creatinine, or therapy duration between toxic and non-toxic groups.
• Concurrent use of furosemide or cephalothin did not show statistical differences.

Conclusions:

• Aminoglycoside-induced auditory toxicity and nephrotoxicity are independent events.
• This independence holds true for approximately 7-day treatment durations with therapeutic serum levels.